Understanding why some children with neuroblastoma have worse survival or respond badly to treatment
Targeting the Fanconi Anaemia pathyway in neuroblastoma
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Targeting the Fanconi Anaemia pathyway in neuroblastoma
Investigation of epigenetic mechanisms of tumour growth control in anaplastic large cell lymphoma
A genome wide study of unresectable, MYCN non-amplied, unfavourable histology neuroblastomas in patients older than 18 months of age
Identifying molecular drivers of disease progression in Ewing’s sarcoma
Teenagers and young adults with primary CNS cancers: a systematic biological characterisation
RNA‐sequencing to characterise malignant rhabdoid tumour heterogeneity: a pilot study in archival frozen material
A pilot study of expression profiling using RNAseq from formalin fixed neuroblastoma and paired diagnostic and relapsed frozen neuroblastomas.
Giving children a voice in healthcare encounters: Implementing a multi-platform interactive technology with children who have cancer
Promoting physical activity in childhood cancer survivors: Using qualitative and co-design methods to inform the development of an evidence-based intervention